1[1]Wallace DC.Diseases of the mitochondrial DNA.Ann Rev Biochem,1992,61:1175.
2[2]Holt IJ,Harding AE,Morgan-Hughes JA.Deletions of mitochondrial DNA in patients with mitochondrial myopathies.Nature,1988,331:717.
3[3]Shoffner JM,Poulton J,Hattori Y,et al.Myoclonic epilepsy and ragged-red fibers disease (MERRF) is associated with a mitochondrial DNA tRNALys mutation.Cell,1990,61:931.
4[4]Wallace DC.Mitochondrial diseases:genotype versus phenotype.Trends Genet,1993,9:128.
5[1]Campos Y. Huertas R,Bautista J, et al. Muscle carnitine deficiency and lipid storage myopathy in pathients with mitochondrial myopathy. Muscle & Nerve, 1993,16∶778～781.
6[2]Garavaglia B, Uziel G, Dworzak F, et al. Primary carnitine deficiency. Heterozygote and intrafamilial phenotypic variation. Neuroloy, 1991,41∶1691～1693.
7[3]Dalakas MC, Leon-Monzon ME, Bernardini Isa, et al. Zidovudineinduced mitochondrial myopathy is associated with muscle carnitine deficiency and lipid storage. Ann Neurol, 1994,35∶482～487.
8[4]Turnbull DM, Shepherd IM, Ashworth B, et al. Lipid storage myopathy associated with low acyl-CoA dehydrogenase activites. Brain, 1988,111∶815～828.
9[5]Patten BM, Shabot JM, Alperin J, et al. Hepatitis-associated lipid storage myopathy. Ann Intern Med, 1977,87∶471～421.
10[6]Arenas J, Gonzalez-Crespo MR, Campos Y, et al. Abnormal carnitine ditribution in the muscles of patients with idiopathic inflammatory myopathy. Arthritis & Rheumatism, 1996,39∶1869～1874.
